FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064139 [Registered on: 14/03/2024] Trial Registered Prospectively
Last Modified On: 05/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Surface microscopy in Leprosy 
Scientific Title of Study   Clinicodermoscopy and Histopathological Associations in various poles of Hansens disease:A cross sectional study. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr.Debadeepta Dey 
Designation  PG Resident Dermatology 
Affiliation  IMS and Sum Hospital 
Address  Post graduate room,Department of SKIN &VD, IMS and Sum Hospital, K8 Kalinga Nagar, Bhubaneswar

Khordha
ORISSA
751003
India 
Phone  6371191053  
Fax    
Email  deydebadeepta@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr.AJAYA KUMAR JENA 
Designation  PROFESSOR 
Affiliation  IMS and Sum Hospital 
Address  Professor room,Department of SKIN & VD,IMS and Sum Hospital, K8, Kalinga Nagar, Bhubaneswar

Khordha
ORISSA
751003
India 
Phone  9437218952  
Fax    
Email  ajayajena@soa.ac.in  
 
Details of Contact Person
Public Query
 
Name  Dr. Debadeepta Dey 
Designation  PG Resident Dermatology 
Affiliation  IMS and Sum Hospital 
Address  Department of SKIN & VD,IMS and Sum Hospital, K8 Kalinga Nagar, Bhubaneswar

Khordha
ORISSA
751003
India 
Phone  6371191053  
Fax    
Email  deydebadeepta@gmail.com  
 
Source of Monetary or Material Support  
IMS & SUM HOSPITAL,K8 Kalinga Nagar,Bhubaneswar 
 
Primary Sponsor  
Name  Not applicable  
Address  Not applicable  
Type of Sponsor  Other [NIL] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Debadeepta Dey  Bhubaneswar  Bhubaneswar
Khordha
ORISSA 
6371191053

deydebadeepta@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: A309||Leprosy, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients above 18years of both sexes clinically suspected of Hansens disease attending the SkIN & VD OPD & Patient who will give consent for biopsy & dermoscopy.  
 
ExclusionCriteria 
Details  Patient who had already taken MDT in the past.
Patient who are not willing for biopsy.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment    
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To evaluate whether dermoscopic features associates with the established histopathological findings in various poles of hansens disease  At baseline 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  Not applicable 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Patient consent will be taken for clinical photographs,dermoscopy & histopathological examination.Dermoscopic evaluation of suspected lesion(more active part) will be taken using a hand held dermlite-II hybrid M dermoscope at 10X magnification in polarised contact mode & photographs will be captured by apple I phone 12 with aid of dermlite app. Both polarised & nonpolarised mode will be used.The same site of the same lesion will also be biopsised & sent for histopathological examination. 
Close